| Literature DB >> 29113410 |
Xin-Sheng Xie1,2,3,4, Jian-Xian Lin1,2,3,4, Ping Li1,2,3,4, Jian-Wei Xie1,2, Jia-Bin Wang1,2,3,4, Jun Lu1,2, Qi-Yue Chen1,2, Long-Long Cao1,2, Mi Lin1,2, Ru-Hong Tu1,2, Chang-Ming Huang1,2,3,4, Chao-Hui Zheng1,2.
Abstract
OBJECTIVES: To investigate risk factors of postoperative hemorrhage (PH) following laparoscopy-assisted radical gastrectomy (LARG) with D2 lymphadenectomy for primary gastric cancer (PGC) and to use those risk factors to develop a scoring system for risk assessment.Entities:
Keywords: D2 lymphadenectomy; gastric cancer; laparoscopy; postoperative hemorrhage; risk factor
Year: 2017 PMID: 29113410 PMCID: PMC5655305 DOI: 10.18632/oncotarget.20828
Source DB: PubMed Journal: Oncotarget ISSN: 1949-2553
The clinicopathological factors between the experimental group and the verification group
| Variables | Experimental group ( | Verification group ( | ||
|---|---|---|---|---|
| Hemorrhage( | No hemorrhage ( | Hemorrhage ( | No hemorrhage ( | |
| ± | ||||
| Male | 27 | 998 | 10 | 308 |
| Female | 7 | 310 | 2 | 127 |
| 63.06 ± 12.79 | 60.43 ± 11.13 | 62.08 ± 16.08 | 60.73 ± 10.88 | |
| 21.47 ± 2.18 | 22.19 ± 3.01 | 22.1 ± 2.22 | 22.2 ± 2.88 | |
| Yes | 6 | 176 | 1 | 68 |
| No | 28 | 1132 | 11 | 367 |
| 48.78 ± 19.29 | 46.27 ± 25.27 | 52.08 ± 25.54 | 46.84 ± 25.77 | |
| Upper | 13 | 304 | 6 | 117 |
| Middle | 2 | 210 | 1 | 64 |
| Lower | 14 | 656 | 3 | 206 |
| Diffuse | 5 | 138 | 2 | 48 |
| I/ II | 6 | 627 | 5 | 218 |
| III | 28 | 681 | 7 | 217 |
| 199.65 ± 62.75 | 190.19 ± 61.72 | 240.00 ± 94.89 | 196.48 ± 67.45 | |
| 118.24 ± 143.43 | 85.73 ± 103.39 | 100.50 ± 80.52 | 84.83 ± 86.88 | |
| 32.13 ± 10.27 | 33.91 ± 13.15 | 31.83 ± 7.03 | 34.71 ± 13.90 | |
| Total | 19 | 623 | 9 | 227 |
| Subtotal | 15 | 685 | 3 | 208 |
| Roux-en-Y | 19 | 622 | 1 | 11 |
| B-I | 9 | 538 | 2 | 156 |
| B-II | 5 | 120 | 0 | 41 |
| Esophagogastric | 1 | 28 | 9 | 227 |
| Yes | 9 | 98 | 5 | 32 |
| No | 25 | 1210 | 7 | 403 |
| Yes | 6 | 36 | 3 | 5 |
| No | 28 | 1272 | 9 | 430 |
| Yes | 3 | 39 | 0 | 12 |
| No | 31 | 1269 | 12 | 423 |
| Yes | 3 | 42 | 1 | 15 |
| No | 31 | 1266 | 11 | 420 |
| 20.09 ± 9.67 | 13.86 ± 7.64 | 19.92 ± 7.28 | 14.36 ± 9.29 | |
PAS: Previous abdominal surgery; PAI: Pure abdominal infection; DTF: Digestive tract fistula; BLDO: blood loss during the operation.
Univariate analysis of PH
| Variables | Early Hemorrhage ( | Later Hemorrhage ( | No Hemorrhage ( | |
|---|---|---|---|---|
| 0.673 | ||||
| Male | 27 | 998 | ||
| Female | 7 | 310 | ||
| 0.192 | ||||
| ≤ 65 | 16 | 473 | ||
| < 65 | 18 | 835 | ||
| 0.093 | ||||
| ≥ 25 | 3 | 269 | ||
| < 25 | 31 | 1039 | ||
| 0.481 | ||||
| Yes | 6 | 176 | ||
| No | 28 | 1132 | ||
| 0.266 | ||||
| ≥ 46 | 19 | 605 | ||
| < 46 | 15 | 703 | ||
| 0.094 | ||||
| Upper | 13 | 304 | ||
| Middle | 2 | 210 | ||
| Lower | 14 | 656 | ||
| Diffuse | 5 | 138 | ||
| 0.000 | ||||
| I/ II | 6 | 627 | ||
| III | 28 | 681 | ||
| 0.475 | ||||
| ≥ 190 | 14 | 461 | ||
| < 190 | 20 | 847 | ||
| ≥ 100 | 22 | 939 | 0.366 | |
| < 100 | 12 | 369 | ||
| 0.001 | ||||
| ≥ 41 | 16 | 306 | ||
| < 41 | 18 | 1002 | ||
| Operation type | 0.342 | |||
| Total | 15 | 685 | ||
| Subtotal | 19 | 623 | ||
| 0.332 | ||||
| Roux-en-Y | 19 | 622 | ||
| B-I | 9 | 538 | ||
| B-II | 5 | 120 | ||
| Esophagogastric | 1 | 28 | ||
| 0.000 | ||||
| Yes | 9 | 98 | ||
| No | 25 | 1210 | ||
| 0.000 | ||||
| Yes | 6 | 36 | ||
| No | 28 | 1272 | ||
| 0.053 | ||||
| Yes | 3 | 39 | ||
| No | 31 | 1269 | ||
| 0.073 | ||||
| Yes | 3 | 42 | ||
| No | 31 | 1266 | ||
| Hospital stay (days) | 20.09 ± 9.67 | 13.86 ± 7.64 | 0.001 |
PAS: Previous abdominal surgery; PAI: Pure abdominal infection; DTF: Digestive tract fistula; BLDO: blood loss during the operation.
Multivariate analysis of PH
| Variables | χ2 | B | OR | 95% CI | Score | |
|---|---|---|---|---|---|---|
| 7.894 | 1.296 | 3.654 | 1.480–9.025 | 0.005 | 1 | |
| 3.993 | 0.739 | 2.094 | 1.014–4.322 | 0.046 | 1 | |
| 5.630 | 1.022 | 2.779 | 1.195–6.463 | 0.018 | 1 | |
| 14.478 | 1.931 | 6.898 | 2.551–18.653 | 0.000 | 2 |
DTF: Digestive tract fistula.
Risk gradation of PH
| Risk gradation | Risk factor score | Case number ( | Hemorrhage rate ( | OR | 95% CI | |
|---|---|---|---|---|---|---|
| 0 | 486(34.9%) | 3 (0.6%) | 1 | / | / | |
| 1 | 568 (42.3%) | 11 (1.9%) | ||||
| 2 | 223 (16.6%) | 11 (4.9%) | ||||
| 3 | 55 (4.1%) | 6 (10.9%) | 8.049 | 3.589–18.084 | 0.000 | |
| 4 | 7 (0.5%) | 1 (14.3%) | ||||
| 5 | 3 (0.2%) | 2 (66.7%) |
Figure 1Receiver operating characteristic (ROC) curves for the logistic regression model and predictive scoring system for bleeding risk after LARG with D2 lymphadenectomy for PGC; the area under the ROC curve was 0.758 (0.674–0.842) for the logistic regression model, and 0.748 (0.663–0.834) for the simplified score system
Hemorrhage condition between the experimental group and verification group with the comparison between actual and predicted incidence of hemorrhage
| Risk gradation | Score | CNEG ( | IEG ( | CNVG ( | IVG ( | |
|---|---|---|---|---|---|---|
| 1277 (95.2%) | 25 (2.0%) | 434 (97.1%) | 9 (2.1%) | 0.881 | ||
| 0 | 486 (34.9%) | 3 (0.6%) | 142 (31.8%) | 1 (0.7%) | ||
| 1 | 568 (42.3%) | 11 (1.9%) | 201 (45.0%) | 3 (1.5%) | ||
| 2 | 223 (16.6%) | 11 (4.9%) | 91 (20.4%) | 5 (5.5%) | ||
| 65(4.8%) | 9(13.8%) | 13(2.9%) | 3(23.1%) | 0.400 | ||
| 3 | 55 (4.1%) | 6 (10.9%) | 11 (2.5%) | 2 (18.2%) | ||
| 4 | 7 (0.5%) | 1 (14.3%) | 2 (0.4%) | 1 (50.0%) | ||
| 5 | 3 (0.2%) | 2 (66.7%) | 0 | / |
CNEG: Case number of experimental group; IEG: Incidence in experimental group.
CNVG: Case number of verification group; IVG: Incidence in verification group.